DekaBank Deutsche Girozentrale’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116M Hold
1,844,793
0.2% 119
2026
Q1
$118M Hold
1,844,793
0.2% 120
2025
Q4
$146M Hold
1,844,793
0.25% 88
2025
Q3
$180M Hold
1,844,793
0.3% 75
2025
Q2
$195M Buy
1,844,793
+147,932
+9% +$15M 0.35% 68
2025
Q1
$165M Sell
1,696,861
-147,932
-8% -$14.9M 0.32% 70
2024
Q4
$165M Hold
1,844,793
0.3% 74
2024
Q3
$155M Sell
1,844,793
-123,389
-6% -$9.73M 0.29% 81
2024
Q2
$154M Buy
1,968,182
+271,321
+16% +$19.9M 0.28% 82
2024
Q1
$116M Buy
1,696,861
+145,754
+9% +$9.37M 0.22% 119
2023
Q4
$88.1M Buy
1,551,107
+688,392
+80% +$36.7M 0.18% 139
2023
Q3
$46M Buy
862,715
+275,864
+47% +$14.5M 0.11% 205
2023
Q2
$31.6M Sell
586,851
-60,932
-9% -$3.18M 0.07% 248
2023
Q1
$32M Sell
647,783
-9,790
-1% -$461K 0.08% 236
2022
Q4
$30.2M Sell
657,573
-12,906
-2% -$559K 0.08% 234
2022
Q3
$26.2M Sell
670,479
-170,457
-20% -$6.84M 0.08% 235
2022
Q2
$31.4M Sell
840,936
-97,081
-10% -$3.95M 0.09% 214
2022
Q1
$42.2M Buy
938,017
+432,489
+86% +$18.7M 0.1% 199
2021
Q4
$21.7M Buy
505,528
+67,885
+16% +$2.85M 0.05% 269
2021
Q3
$19.1M Sell
437,643
-109,057
-20% -$4.82M 0.05% 269
2021
Q2
$23.4M Sell
546,700
-28,270
-5% -$1.19M 0.07% 245
2021
Q1
$22.3M Buy
574,970
+33,345
+6% +$1.26M 0.07% 234
2020
Q4
$19.5M Buy
541,625
+95,637
+21% +$3.45M 0.07% 237
2020
Q3
$16.6M Buy
445,988
+156,325
+54% +$6.02M 0.07% 227
2020
Q2
$9.96M Sell
289,663
-170,376
-37% -$6.14M 0.06% 207
2020
Q1
$14.4M Buy
460,039
+156,920
+52% +$6.13M 0.11% 139
2019
Q4
$13.6M Sell
303,119
-57,715
-16% -$2.42M 0.08% 180
2019
Q3
$14.7M Sell
360,834
-82,440
-19% -$3.49M 0.09% 205
2019
Q2
$18.8M Buy
443,274
+101,379
+30% +$3.9M 0.09% 230
2019
Q1
$12.3M Buy
341,895
+26,525
+8% +$1.01M 0.07% 269
2018
Q4
$11M Sell
315,370
-26,525
-8% -$962K 0.07% 246
2018
Q3
$12.3M Buy
341,895
+17,581
+5% +$614K 0.07% 271
2018
Q2
$10.7M Buy
324,314
+5,891
+2% +$178K 0.07% 284
2018
Q1
$8.74M Buy
318,423
+13,301
+4% +$362K 0.06% 310
2017
Q4
$8.29M Hold
305,122
0.06% 279
2017
Q3
$8.29M Sell
305,122
-5,137
-2% -$142K 0.06% 279
2017
Q2
$8.76M Sell
310,259
-7,089
-2% -$188K 0.07% 277
2017
Q1
$7.86M Buy
317,348
+106,533
+51% +$2.59M 0.07% 254
2016
Q4
$4.56M Sell
210,815
-125,009
-37% -$2.73M 0.05% 327
2016
Q3
$7.83M Sell
335,824
-29,500
-8% -$704K 0.09% 230
2016
Q2
$8.42M Buy
365,324
+70,280
+24% +$1.52M 0.1% 220
2016
Q1
$5.54M Buy
295,044
+30,207
+11% +$531K 0.07% 288
2015
Q4
$4.97M Buy
264,837
+27,300
+11% +$489K 0.06% 319
2015
Q3
$3.85M Sell
237,537
-17,151
-7% -$293K 0.05% 354
2015
Q2
$4.58M Sell
254,688
-27,226
-10% -$487K 0.05% 311
2015
Q1
$5.05M Buy
281,914
+33,112
+13% +$523K 0.06% 305
2014
Q4
$3.29M Buy
248,802
+3,800
+2% +$48.6K 0.04% 387
2014
Q3
$2.92M Buy
245,002
+91,554
+60% +$1.15M 0.04% 375
2014
Q2
$1.97M Buy
153,448
+28,634
+23% +$372K 0.03% 420
2014
Q1
$1.66M Sell
124,814
-33,500
-21% -$440K 0.03% 403
2013
Q4
$1.9M Buy
158,314
+24,100
+18% +$285K 0.03% 334
2013
Q3
$1.53M Sell
134,214
-16,059
-11% -$174K 0.03% 355
2013
Q2
$1.39M Buy
+150,273
New +$1.27M 0.03% 319

Other funds holding BSX

DekaBank Deutsche Girozentrale's BSX Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Boston Scientific (BSX) position steady in Q2 2026 at 1,844,793 shares worth $116M. The position accounts for 0.2% of the portfolio, ranked #119.

DekaBank Deutsche Girozentrale first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $195M in Q2 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • DekaBank Deutsche Girozentrale held 1,844,793 shares of Boston Scientific worth $116M as of Q2 2026.
  • DekaBank Deutsche Girozentrale left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.2% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #119 holding.
  • DekaBank Deutsche Girozentrale first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • DekaBank Deutsche Girozentrale's Boston Scientific position peaked at $195M in Q2 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.